TATVA

Tatva Chintan Pharma Chem Limited

Specialty chemicals maker of Phase Transfer Catalysts and electrolytes

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

tatvachintan.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1944.00
Market cap
4,549 Cr
Stock P/E
88.5
P/B
5.82
Dividend yield
0.1%
ROE (FY26)
5.4%
ROCE (FY26)
6.6%
Operating margin (FY26)
11.1%
Debt / equity (FY26)
0.15
OCF / EBITDA (FY26)
33.8%
OCF / EBITDA (3Y)
78.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Tatva Chintan (Tatva Chintan Pharma Chem) makes specialty chemicals, including phase transfer catalysts, electrolyte salts and intermediates for pharma and agro customers, and sells them to chemical-industry customers in India and abroad.

Company snapshot

25thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Debt-to-equity of 0.15x — the company is largely funded by its own money, not borrowed funds.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales97 Cr84 Cr98 Cr105 Cr83 Cr86 Cr108 Cr117 Cr124 Cr131 Cr134 Cr167 Cr
Operating expenses (approx.)76 Cr73 Cr83 Cr93 Cr78 Cr79 Cr99 Cr100 Cr101 Cr106 Cr106 Cr135 Cr
EBITDA20 Cr11 Cr16 Cr13 Cr6 Cr7 Cr9 Cr17 Cr22 Cr25 Cr28 Cr32 Cr
OPM %20.9%13.1%15.9%12.0%6.7%8.2%8.3%14.8%18.0%19.4%21.0%19.3%
Other income0.76 Cr1 Cr5 Cr1 Cr0.38 Cr0.04 Cr0.72 Cr1 Cr1 Cr2 Cr-0.35 Cr3 Cr
Interest3 Cr0.38 Cr0.21 Cr0.31 Cr0.17 Cr0.42 Cr0.39 Cr0.41 Cr0.51 Cr0.49 Cr1 Cr2 Cr
Depreciation7 Cr7 Cr6 Cr7 Cr7 Cr7 Cr7 Cr9 Cr9 Cr9 Cr10 Cr11 Cr
Profit before tax11 Cr5 Cr14 Cr7 Cr-1 Cr-0.23 Cr2 Cr9 Cr14 Cr18 Cr17 Cr21 Cr
Tax %30.6%34.1%29.8%23.5%35.0%158.7%49.2%26.9%27.4%14.1%37.8%24.3%
Net profit8 Cr3 Cr10 Cr5 Cr-0.66 Cr0.14 Cr1 Cr7 Cr10 Cr15 Cr10 Cr16 Cr
EPS (₹)₹3.43₹1.48₹4.11₹2.23₹-0.29₹0.06₹0.44₹2.84₹4.24₹6.49₹4.41₹6.83

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales206 Cr263 Cr300 Cr434 Cr424 Cr394 Cr383 Cr506 CrSign in free for the trailing twelve months
Operating expenses (approx.)173 Cr208 Cr235 Cr325 Cr363 Cr325 Cr349 Cr413 CrSign in free for the trailing twelve months
EBITDA34 Cr55 Cr66 Cr108 Cr61 Cr68 Cr34 Cr93 CrSign in free for the trailing twelve months
OPM %16.4%20.9%21.9%25.0%14.3%17.3%8.9%18.4%Sign in free for the trailing twelve months
Other income0.49 Cr1 Cr6 Cr9 Cr6 Cr8 Cr2 Cr4 CrSign in free for the trailing twelve months
Interest4 Cr4 Cr4 Cr5 Cr8 Cr7 Cr1 Cr3 CrSign in free for the trailing twelve months
Depreciation4 Cr5 Cr7 Cr8 Cr10 Cr26 Cr28 Cr37 CrSign in free for the trailing twelve months
Profit before tax27 Cr48 Cr61 Cr104 Cr45 Cr44 Cr8 Cr57 CrSign in free for the trailing twelve months
Tax %25.0%20.6%13.9%7.9%-1.6%30.3%24.6%26.2%Sign in free for the trailing twelve months
Net profit21 Cr38 Cr52 Cr96 Cr45 Cr30 Cr6 Cr42 CrSign in free for the trailing twelve months
EPS (₹)₹10.23₹18.81₹26.02₹44.59₹20.52₹13.26₹2.44₹17.98Sign in free for the trailing twelve months
Dividend payout %———0.0%9.7%15.4%81.9%5.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital8 Cr8 Cr20 Cr22 Cr22 Cr23 Cr23 Cr23 Cr
Reserves72 Cr110 Cr146 Cr451 Cr493 Cr714 Cr715 Cr758 Cr
Borrowings71 Cr79 Cr76 Cr120 Cr170 Cr14 Cr36 Cr120 Cr
Other liabilities36 Cr52 Cr73 Cr65 Cr71 Cr67 Cr61 Cr102 Cr
Total liabilities188 Cr249 Cr315 Cr658 Cr756 Cr819 Cr836 Cr1,004 Cr
Fixed assets (net)54 Cr99 Cr109 Cr159 Cr196 Cr427 Cr526 Cr604 Cr
CWIP6 Cr5 Cr10 Cr51 Cr231 Cr73 Cr22 Cr23 Cr
Investments———0 Cr0 Cr10 Cr0 Cr4 Cr
Loans & advances———0.16 Cr0.17 Cr0.24 Cr0.24 Cr0.27 Cr
Inventories36 Cr64 Cr72 Cr170 Cr162 Cr153 Cr134 Cr196 Cr
Trade receivables41 Cr50 Cr91 Cr57 Cr84 Cr70 Cr83 Cr119 Cr
Cash & bank15 Cr10 Cr4 Cr63 Cr27 Cr35 Cr11 Cr6 Cr
Other assets35 Cr22 Cr29 Cr158 Cr55 Cr51 Cr61 Cr51 Cr
Total assets188 Cr249 Cr315 Cr658 Cr756 Cr819 Cr836 Cr1,004 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity7 Cr25 Cr24 Cr20 Cr28 Cr98 Cr25 Cr31 Cr
Cash from investing-17 Cr-40 Cr-21 Cr-197 Cr-101 Cr-121 Cr-65 Cr-116 Cr
Cash from financing17 Cr10 Cr-9 Cr235 Cr38 Cr31 Cr17 Cr79 Cr
Net cash flow8 Cr-5 Cr-5 Cr59 Cr-36 Cr8 Cr-24 Cr-6 Cr
Free cash flow (OCF − Capex)-2 Cr-23 Cr3 Cr-69 Cr-175 Cr-30 Cr-52 Cr-82 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %20.5%26.2%26.8%18.4%7.8%6.7%1.1%6.6%
ROE %25.8%32.1%31.5%20.3%8.8%4.1%0.8%5.4%
Debtor days73691104873657886
Inventory days110159174243274312281272
Days payable68791156454926881
Cash conversion cycle114149169227292285291277
OCF / EBITDA %21.8%46.1%37.0%18.8%45.9%143.8%72.1%33.8%
OCF / EBITDA % (3 years)——36.9%30.6%30.9%61.7%92.3%78.8%
Debt / equity0.900.670.460.250.330.020.050.15
Current ratio1.571.511.562.541.333.742.761.64
Net debt / EBITDA1.671.261.090.532.36-0.310.731.23